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Abstract
Background: Herpesvirus genes are classified into distinct kinetic groups on the basis of their expression dynamics
during lytic growth of the virus in cultured cells at a high, typically 10 plaque-forming units/cell multiplicity of
infection (MOI). It has been shown that both the host response and the success of a pathogen are dependent on
the quantity of particles infecting an organism. This work is a continuation of an earlier study [1], in which we
characterized the overall expression of PRV genes following low-MOI infection. In the present study, we have
addressed the question of whether viral gene expressions are dependent on the multiplicity of infection by
comparing gene expressions under low and high-MOI conditions.
Results: In the present study, using a real-time RT-PCR assay, we address the question of whether the expression
properties of the pseudorabies virus (PRV) genes are dependent on the number of virion particles infecting a single
cell in a culture. Our analysis revealed a significant dependence of the gene expression on the MOI in most of
these genes. Specifically, we found that most of the examined viral genes were expressed at a lower level at a low
MOI (0.1) than at a high MOI (10) experiment in the early stage of infection; however, this trend reversed by six
hour post-infection in more than half of the genes. Furthermore, in the high-MOI infection, several PRV genes
substantially declined within the 4 to 6-h infection period, which was not the case in the low-MOI infection. In the
low-MOI infection, the level of antisense transcript (AST), transcribed from the antiparallel DNA strand of the
immediate-early 180 (ie180) gene, was comparable to that of ie180 mRNA, while in the high-MOI experiment
(despite the 10 times higher copy number of the viral genome in the infected cells) the amount of AST dropped
by more than two log values at the early phase of infection. Furthermore, our analysis suggests that adjacent PRV
genes are under a common regulation. This is the first report on the effect of the multiplicity of infection on
genome-wide gene expression of large DNA viruses, including herpesviruses.
Conclusion: Our results show a strong dependence of the global expression of PRV genes on the MOI.
Furthermore, our data indicate a strong interrelation between the expressions of ie180 mRNA and AST, which
determines the expression properties of the herpesvirus genome and possibly the replication strategy (lytic or
latent infection) of the virus in certain cell types.
Background
Pseudorabies virus (PRV), an alpha-herpesvirus, and the
causative agent of Aujeszky’s diseases of swine [2], is a
commonly used model organism for studies in patho-
genesis and the molecular biology of herpesviruses.
Furthermore, it is widely utilized as a neural circuit tra-
cer [[3,4] and [5]] and has been reported to be suitable
as a vector for gene delivery to various cells [6,7] and as
an oncolytic agent [8]. The gene expressions of herpes-
viruses are currently undergoing intensive investigation
in consequence of the development of new technologies
allowing simultaneous analysis of the expressions of
multiple genes. DNA microarray approaches have been
applied for the overall analysis of herpesvirus gene
expression in several studies [[9,10] and [11]]. Microchip
techniques are powerful tools that permit simultaneous
measurement of the relative changes in quantity of
thousands of genes of an organism, and the comparison
of gene expression profiles under various circumstances.
Quantitative real-time RT-PCR is a much more sensitive
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any medium, provided the original work is properly cited.and accurate method, but, at least at present, it is not
well suited for the analysis of large numbers of samples.
The herpesvirus genome however is, within the range
that can be successfully analysed with this technique [1].
The program of herpesvirus gene expression is con-
trolled at multiple levels by complex interactions
between viral and cellular factors. The lytic gene expres-
sions of herpesviruses are strictly coordinated in a
sequential cascade manner and are traditionally subdi-
vided into immediate-early (IE), early (E) and late (L)
phases. IE proteins are involved in the control of the
synthesis of E and L genes. The IE180 gene (ie180;
h o m o l o g u eo ft h eH S VI C P 4g e n e )i st h eo n l yI Eg e n e
of PRV, and the most important regulator of viral gene
expression. The E genes of herpesviruses are involved in
various aspects of DNA synthesis, while most L genes
mainly encode the structural elements of the virus. The
antisense transcripts LLT (long latency transcript) and
LAT (latency-associated transcript) overlapping the
ICP4 and ICP0 (a homologue of ep0 in PRV), respec-
tively, are reported to play important roles in the estab-
lishment of latency in HSV [12]. It has not yet been
unequivocally clarified whether the expression of anti-
sense transcript produced by the complementary DNA
strand of the ie180 gene is controlled solely by the LAP
(LAT promoter) producing LLT or also by a putative
promoter (antisense promoter, ASP) localized on the
inverted repeat of the PRV genome, producing a shorter
transcript. In this study, we use the term ‘antisense tran-
script’ (AST) for the RNA molecule transcribed from
the complementary DNA strand of the ie180 gene.
It is well known that both the host response and the
success of a pathogen are dependent on the quantity of
particles infecting an organism; and, specifically in her-
pesviruses, the infecting dose determines whether the
virus enters a latent state or induces an acute infection
[13]. A further important question is whether the global
gene expression profile of the virus genome is dependent
on the number of virus particles entering the cells. In
both traditional and microarray studies, herpesvirus gene
expression has been analysed by using a relatively high
multiplicity of infection, typically MOI~10 plaque-
forming unit (pfu)/cell [9-11]. Theoretically, it is possible
that herpesviruses express their genomes in a different
manner when only a single virus particle infects a cell as
compared with the situation when multiple virions enter
a cell. In the present study, we addressed this issue by
using low (0.1 pfu/cell) and high (10 pfu/cell) MOIs for
the infection of cultured porcine kidney epithelial cells
with wild-type PRV, and subsequently analysed and com-
pared the expressions of 37 PRV genes and two antisense
transcripts (AST and LAT) using the SYBR Green-based
real-time RT-PCR technique.
Results and Discussion
Experimental design
In this study, PK-15 cells were infected with pseudora-
b i e sv i r u sa tM O I so f0 . 1a n d1 0 .A l b e i tt h ed i f f e r e n c e
in the infectious dose in the two parallel experiments
was 100-fold, an individual cell was invaded by only
10 times more virus particles in the high-MOI than in
the low-MOI experiment (5 × 10
6 versus 5 × 10
5
infected cells), the reason for this being that in the latter
case approximately 90% of the cells remained unin-
fected. Cells were harvested at 0, 1, 2, 4 and 6 h post-
infection (pi), as in our earlier report [1]. We used 6 h
as the maximum infection period in order to exclude
the possibility of the initiation of new infection cycles in
the low-MOI experiment. In this study, we analysed the
expression of 37 genes (53% of the total PRV genes) and
two antisense transcripts (AST and LAT) (Figure 1 and
2[14-45]). For the calculation of relative expression
ratios (Rs) (Additional file 1a), we used the average 6 h
E
Ct values of the high-MOI experiments of both the
“samples” and the “references” as controls, as in our ear-
lier publication [1]. We used a correction factor of
10 for the calculation of R for the low-MOI experiment
(Additional file 2a). With this calculation technique,
approximately the same numbers of infected cells, and
hence the relative amounts of transcripts in an average
infected cell, were compared in the two experiments.
However, in the high-MOI experiment, the proportion
of the genome copy number in an infected cell was also
10-fold higher on average, at least before the start of
viral DNA replication (the first 2 h pi), the reason for
this being that in the high-MOI experiment 10 virus
particles infected an average cell, while in the low-MOI
infection 10 per cent of the cells were infected with a
single virus particle. Thus, to compare the gene expres-
sions from a single virus DNA per cell, two normaliza-
tions are necessary: multiplication of the R values of the
low-MOI data by 10, and division of the R values of the
high-MOI data by 10. In some calculations, the original
data were handled accordingly (see the indications in
the particular cases). The relationship between the infec-
tious dose and the genome copy number of PRV
becomes non-linear in later stages of viral infection; the
DNA copy numbers in the two experimental situations
are therefore not comparable on the basis of the infec-
tious dose. The R values of LAT and AST were calcu-
lated by using the 6 h E
Ct values of the corresponding
genes, ep0 and ie180, respectively, as the reference gene.
RΔ values were used to monitor the net change in the
quantity of viral transcripts within a given period of
time (Additional file 2b). Ra shows the ratio of the
changes in the amounts of transcripts between two adja-
cent time points (Additional file 2c).
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Page 2 of 11We considered two principles for the selection of
genes for expression analyses. (1) We analysed the
upstream genes of each nested gene cluster, the reason
for this being that these genes are not overlapped by
other genes, and the amounts of these transcripts are
therefore proportional to their protein products. This is
in contrast with the downstream genes, which, if tran-
scribed from the promoter of an upstream gene, are not
translated, because they do not have cap sequences that
are required for the recognition by the ribosomes.
Figure 1 Localization of PRV genes on the viral genome. This Figure shows the genomic locations of the PRV genes. The direction of
transcription is indicated by the arrows. Grey boxes indicate examined genes. Broken-line boxes show the known antisense transcripts of PRV.
Unexamined genes are shown as white boxes.
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Page 3 of 11(2) Furthermore, we analysed genes that are of primary
importance in the regulation of global viral gene expres-
sion, such as ie180, ep0, vhs and ul54.
Gene expressions in the early stage of PRV infection
In the first 2 h of infection, the viral DNA replication
has not yet been initiated, and the copy number of viral
genomes in a cell therefore corresponds with the infec-
tious dose. In this analysis, we found that the mRNA
levels of most examined PRV genes were higher in the
cells infected with the high MOI than in those infected
with the low MOI (Additional file 2a) at both 1 h and
2 h pi. This was not unexpected since in the former
case viral DNAs were represented in an approximately
10-fold higher proportion in an average infected cell.
Exceptions to this were the transcripts ul1, ul33,a n d
ul51 mRNAs at 1 h pi, and ul36, ul38, ul43,a n dul48
m R N A sa t2hp i ,a n da tb o t h1ha n d2h :ie180 and
ul30 mRNAs, as well as, LAT and AST. However, the
expression levels normalized to the genome copy
Gene name (¶)  Kinetic class
§            Function                             References 
ul54 (¶ICP27)    E    ¶transcription regulator            [14] 
ul52  E   ¶helicase-primase  complex          [15] 
ul51 L    protein-protein  interaction tegument     [16] 
ul50 (¶dUTPase)  E    dUTPase, virulence faktor           [17] 
ul49.5 (gN)  L    virion entry, egress             [18] 
ul48 (¶VP16, Į-TIF)  L    virion formation, gene regulator    [19] 
ul29 (¶ICP8)  E    DNA replication, DNA binding    [20] 
ul30  E    ¶DNA polymerase, replication    [21] 
ul32  L    DNA cleavage and encapsidation        [22] 
ul33  L    DNA cleavage and packaging               [22] 
ul36 (¶VP1/2)  L    virion morphogenesis                           [23] 
ul37  L    viral egress              [23] 
ul38 (¶VP19c)   L    virion production                 [24] 
ul41 (VHS)  L   RNase  activity    [25]         
ul42  L   DNA  replication     [26]        
ul43  E/L   modulating  fusion  processes    [27] 
ul44 (gC)  L    viral entry, virion attachment     [28] 
ul24 (¶VP24)  L    unknown              [29] 
ul23 (TK)    E     nucleotide synthesis        [26] 
ul22 (gH)     L    viral entry, cell-cell spread      [30] 
ul21   E    capsid maturation               [31] 
ul20   E/L    viral egress                        [32]      
ul19 (¶VP5)  L    virion production, capsid protein      [33] 
ul17   L    DNA cleavage and packaging           [34] 
ul15   E/L    DNA cleavage and encapsidation     [35]     
ul14  E/L    ¶unknown                [36] 
ul10 (gM)   L    membrane fusion               [36]   
ul9 (¶OBP)  E    DNA synthesis                  [37] 
ul6  L    Capsid protein, portal protein             [38] 
ul5   L    DNA replication               [39] 
ul1 (gL)  L    viral entry, cell-to-cell spread           [38] 
LAT  L    ¶latency                 [39] 
AST   E    ¶latency                 [39] 
ep0 (¶ICP0)  E    gene regulation               [40]     
ie180 (¶ICP4)  E/L    gene regulation              [41] 
us1 (¶RSp40/ICP22)  L    ¶regulator of gene expression           [42] 
us3 (PK)  E    egress, cell-to-cell spread             [43] 
us6 (gD)  E/L    viral entry                 [44] 
us9 (¶11K)  E/L    anterograde spreed of virus            [45] 
 
¶- HSV homologue/function 
§ -[11] 
Figure 2 List of PRV genes analysed in this study. This Figure presents the kinetic classification of the examined PRV genes, and their
functional assignment.
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Page 4 of 11number (i.e. using R/10 values in the high-MOI infec-
tion) showed an inverse pattern: only a few genes were
expressed at higher abundance in the high-MOI than in
low-MOI infection (Additional file 2a). AST was
expressed at a considerably higher quantity in the cells
infected with the low MOI than in those infected with
the high MOI (Rlow MOI/Rhigh MOI = 111-fold at 1 h, and
298-fold at 2 h pi). The expression rate of a single geno-
mic region encoding the AST was even 10 times higher
(1 h: 1110-fold and 2 h: 2980-fold) in the low-dose
infection experiment (Additional file 2a). In the high-
dose infection 6 of the 37 genes (ie180, ul36, ul50, ul54,
us1,a n dul24) exhibited higher expression levels at 1 h
than at 2 h pi. It should be noted that 3 of them (ie180,
us1 and ul54) are regulatory genes. The fourth regula-
tory PRV gene, ep0, is expressed at a very high level
during the first 2 h in the high-MOI infection (R1h=
1.87, R2h= 2.05). Apart from ep0, ul5 (R2h=1 . 2 )w a s
the only gene that was expressed at a higher extent in
the early stages of infection than at 6 h pi in the high-
MOI experiment. The ie180 g e n ei st h eo n l yo n et h a t
was expressed in a higher amount at 1 h than at 2 h pi
under both experimental conditions (Additional file 2).
Overall, it appears that the 4 regulatory genes were
expressed at relatively high levels before the onset of
DNA replication in the high-MOI infection, which was
not the case in low-MOI infection, with the exception
of the ie180 gene. We think that the reason for the
higher expression of regulatory genes at the onset of
viral DNA replication in the high-MOI infection is that
more regulatory proteins are needed to carry out the
multiplication of a higher copy number of the viral gen-
ome. The rate of change in gene expression within the 1
ht o2hi n t e r v a l( R 2h/R1h) was higher in more than
two-thirds of the PRV genes (25/37) in the low-MOI
than in the high-MOI infection (Additional file 2c). The
proportion of AST to ie180 mRNA molecules (RAST/
Rie180) was 0.47 at 1 h pi, and 4.72 at 2 h pi in cells
infected with the low MOI, while this ratio was extre-
mely low (~0.01) at both 1 h and 2 h pi in the high-
MOI infection (these data are only semi-quantitative
since the primer efficiencies in the RT reaction are not
necessarily equal for the two transcripts). Thus, the pro-
portion of AST to ie180 mRNA [(RAST-low MOI/Rie-low
MOI)/(RAST-high MOI)/Rie-high MOI)] was 39-fold higher at
1 h pi and 293-fold higher at 2 h pi in the low-MOI
than in the high-MOI infection. In the early stages of
PRV infection, the amount of AST was very high; it
even significantly exceeded the level of ie180 mRNAs at
2 h pi in the low-MOI infection, while the amount of
AST and also its ratio to ie180 mRNA were extremely
low in the high-MOI infection. Moreover, ie180 mRNA
is expressed to a significantly higher extent in the low-
MOI experiment despite the 10 times lower copy
number of PRV DNA in an infected cell, which is espe-
cially important because IE180 is a DNA-binding pro-
tein. We think that this observation reveals an
important regulatory mechanism of the herpesviruses,
which is as follows: in a high-titre infection, the virus
initiates a lytic infection in a cell, while in a low-titre
infection, the virus has the choice of whether to estab-
lish a dormant state or enter a lytic cycle in a cell. The
molecular mechanism of this phenomenon might be
based on the interaction of ie180 and AST genes at
both the transcription and translation levels. (1) The
ie180 protein might exert a negative effect on the synth-
esis of AST, such as in LAT in HSV [46] by binding the
promoter of the antisense transcript. (2) Furthermore,
the complementary transcripts might mutually influence
each other’s expression transcript by RNA-RNA interac-
tion. In a low-MOI infection, the two transcripts exhibit
a complementary expression pattern, which indicates a
competition between the two transcripts. In a high-MOI
infection, however, the high initial amount of ie180 gene
product inhibits the expression of AST. The significance
of this infection strategy could be that, in the case of a
low-amount infection, the virus has no chance to invade
the host cells; therefore, it is better to hide against the
immune surveillance.
The ep0 gene is expressed in higher quantity at both 1
h pi (4.22-fold) and 2 h pi (2.43-fold) in the high-MOI
infection than in low-MOI infection, which is in con-
trast with LAT, its antisense partner, whose expression
level was lower in the high-MOI infection (1 h: 0,5-fold;
2h :0 , 1 8 - f o l d ) .T h u s ,t h er a t i o so fL A Tt oep0 mRNA
molecules were 8.33-fold higher at 1 h pi and 13.05-fold
higher at 2 h pi in the low-MOI than in the high-MOI
experiment, although, unlike AST, LAT is abundantly
expressed in the high-MOI infection. Accordingly, simi-
larly to AST, LAT is expressed in a significantly higher
proportion to ep0 mRNA in the low-MOI infection in
the early stages of infection, which may also be impor-
tant as concerns of the replication strategy of the virus.
Our analyses additionally showed that AST and LAT
are, at least partly, expressed independently from each
other, which supports the existence of separate elements
controlling the expressions of the two antisense tran-
scripts. Indeed, AST was suggested to be controlled by
an antisense promoter (ASP) localized in the outer
regions of inverted repeats [47].
Gene expressions in later stages of PRV infection
At 4 h pi the transcript levels of more than three-quarters
of the PRV genes (28/37) were still higher in the cells
infected with the high MOI than in those infected with
the low MOI (Additional file 2c). However, in about two-
third of the viral genes the rate of change (Ra values) in
the expression level was higher in the low-MOI than in
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Page 5 of 11the high-MOI infection (24/37 within the 2 h to 4 h per-
iod, and 25/37 within the 1 h to 4 h period) (Additional
file 2c). In the low-MOI infection, the amounts of 5 tran-
scripts (ul5, ul44, us1 and us6) were less than 10% of
those in the high-MOI infection at 4 h pi. All of the
examined us genes are expressed at a significantly lower
level in the low-than in the high-titre infection at 4 h pi.
There were significant decreases in the quantities of both
AST and LAT in the low-titre infection at 4 h pi relative
to the 2 h values (AST: a 59-fold decrease, and LAT: a
7-fold decrease). We explain this phenomenon by the
negative effect of the regulatory genes on their antisense
partners. Regulatory genes are upregulated at the onset
of DNA replication (in order to facilitate this process),
which exerts an inhibitory effect on the expression of
AST and LAT. In contrast, there were increases in the
amounts of antisense transcripts in the high-MOI (AST:
an 11-fold increase, and LAT: a 7-fold increase) in this
time interval. However, while LAT was expressed at high
level (R = 1.3) under the high-MOI conditions, the AST
expression remained extremely low (R = 0.013) in this
period of infection. The amount of the ie180 transcript
was practically unchanged within the 2 h to 4 h infection
period under either infection conditions. There was a
4.7-fold increase in the ep0 mRNA level within the 2 h to
4 h infection period (R4h/R2h) in the low-MOI infection,
as compared with only 1.4 in the high-MOI experiment.
On average, the amounts of mRNAs in low titre infection
became higher than those in the high-infection titre by
6 h pi in more than half of the PRV genes (22/37). We
assume that the reason for this might be that the ie180
gene, the major coordinator of gene expression, is
expressed at higher levels at 4 and 6 h pi at low-MOI
than at high-MOI infection. Moreover, in the high-MOI
infection the amount of AST reached almost 30% of the
transcript level in the low-MOI infection, while LAT was
expressed at approximately the same level under the two
infection conditions at 6 h pi. The genes expressed at
lower levels in the low-dose infection appeared to be
clustered on adjacent genomic locations (Figure 1). Each
gene and the two antisense transcripts were expressed at
higher rates (Ra values) within the 4 h to 6 h period in
the low-MOI than in the high-MOI infection without
exception (Additional file 1c). In the high-MOI infection,
11 genes and LAT peaked at 4 h within the 6-h examina-
tion period, while in the low-MOI infection only the us3
transcript had a slightly lower R value at 6 h than at 4 h
pi. The us3 gene was the only one among the 70 PRV
genes which was expressed at a higher level at 4 h than at
6 h pi in another study [1]. Intriguingly, the ep0 mRNAs
reached a 3.5-fold higher level in the low-dose than in
t h eh i g h - d o s ei n f e c t i o ni na na v e r a g ec e l la t6hp i .
Furthermore, at 6 h pi the ul1 and ul51 genes were
expressed at an approximately 10 times higher level
under the low-MOI than under the high-MOI
conditions.
Gene expression kinetics within the 0 to 6-h infection
period
The expression of most PRV genes basically differed
under the two infection conditions (Additional file 1c),
which is in contrast with the case of rhesus monkey rha-
dinovirus (a g-herpesvirus), whose lytic gene expression
commences at a fixed pace in infected cells, regardless
of the MOI [48]. Most genes were expressed at a lower
level in a cell in the low-MOI experiment in the first
4ho fi n f e c t i o n ,b u tm o r et h a nh a l fo ft h e s eg e n ep r o -
ducts surpassed the high-MOI values by 6 h pi. The R
values of 3 PRV genes (ie180, ul1 and ul30) were higher
in the low-MOI than in the high-MOI infection at every
examined time point, while the opposite was true (the
R values of high-MOI were always higher) in 13 genes:
ul5, ul15, ul17, ul19, ul23, ul24, ul44, ul49.5, ul54, us6,
us9, us1 and us3 (Figure 3). These latter genes form
clusters on the basis of their localization on the genome
(genes in close vicinity are underlined), which suggests
that the adjacent genomic sequences might be under
common regulatory control. This observation is sup-
ported by the similarity of the Ra curves of adjacent
genes (Additional file 1c). For example, the expression
rates of the ul36, ul37 and ul38 genes were similar to
each other in both experiments, but each of them exhib-
ited an inverse expression pattern in the two infection
conditions. All genes were expressed at a higher rate
(Ra) within the 1 h to 6 h period of infection in the low-
titre experiment, except for ie180 and the two antisense
transcripts. The quantities of ie180 mRNAs were similar
in the two experiments, except at 1 h pi, where the level
of the transcripts was 2.8-fold higher in the low-MOI
infection. Thus, the amount of total ie180 transcript in
an infected cell appears to be under strict control, inde-
pendently of the initial infection conditions. In contrast,
the expression of the ep0 gene differed basically in the
two experiments. In the high-MOI experiment, the
amount of ep0 mRNAs was high from the first hour of
infection, and its expression even declined by 6 h in the
high-MOI infection, while the amount of these tran-
scripts rapidly increased throughout the 6-h infection
period in the low-dose infection, and reached a 3.5-fold
higher level compared to that of the high-dose infection
by 6 h. (Figure 4) The ratio of sense and antisense tran-
scripts during the 6-h infection period displayed intri-
guing patterns. First of all, in the high-MOI infection
the amount of AST and its ratio to ie180 mRNA were
very low throughout the 6-h infection period. We
demonstrated an inverse relationship in the expression
kinetics of ie180 m R N Aa n dA S Ta n da l s oep0 mRNA
and LAT in the low-MOI infection; however, we did not
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Page 6 of 11observe this inverse relationship between the comple-
mentary transcripts under the high-MOI conditions
(Figure 5). In an earlier report [1], we showed that treat-
ment of infected cells with cycloheximide (a protein
synthesis blocker) resulted in significant increases in the
amounts of both ie180 mRNA and AST, while phospho-
noacetic acid (a DNA synthesis inhibitor) treatment led
to a decrease in ie180 mRNA and a significant increase
in the AST level. These results suggest a negative effect
of the IE180 transactivator on ASP synthesis. We
explain the huge drop in ASP level in the infected cells
in the early stage of the high-MOI infection by the
presence of a 10-fold higher amount of inhibitory IE180
protein localized in the tegument of the infecting virions
[49]. The same reason could account for the lower ie180
mRNA level in the high-MOI infection. The us1 gene
was expressed in the late kinetics in our earlier low-
MOI analysis in both phophonoacetic acid-treated and
non-treated samples. These results are in concordance
with those of the present high-dose infection experi-
ment, i.e. us1 mRNA was expressed at a relatively low
level at 1 h, which even dropped by 2 h pi. The highest
rate of us1 mRNA expression was observed at 4 h, with
ar a t e( R 4h / 2h= 13.32) typical of L genes. The Pearson
correlation coefficients of the R, RΔ,a n dR a values pre-
cisely show the degree of similarity (or differences) of
the expression kinetics of the genes in the low- and
high-MOI experiments (Additional file 3). Several genes
exhibited high correlations for all three parameters. For
example, the ie180, ul19, ul21, ul22, ul42 and ul43
Figure 3 Heatmap-like representation of the ratio of
transcripts produced in the low-MOI and high MOI infection
(Rt low MOI/Rt high MOI). PK-15 cells were infected with the PRV-Ka
strain at different MOIs (0.1 and 10). Real-Time PCR data were
normalised to 28 S RNAs. The Rlow/Rhigh values are plotted in a heat
map-like manner. Black boxes indicate the highest ratio, and dark-
red boxes the lowest values. White boxes demonstrate
approximately equal values.
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Figure 4 The ratio of ie180 and ep0 mRNAs to their antisense
partners. The continuous lines illustrate the ratio of ie180 mRNA to
AST, while the dotted lines represent the ratio of ep0 mRNA to LAT
at the low- and high-MOI infections.
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and Ra values. The us1 g e n eb e h a v e di na ni r r e g u l a r
manner; it gave a relatively high correlation for the R
values, no correlation of RΔ, and an inverse correlation
for the Ra values. AST yielded relatively high negative
values for all three parameters, indicating a significant
negative correlation. The expressions of LAT under the
two experimental conditions did not correlate on the
basis of the R values, whereas it gave a very high nega-
tive correlation for its RΔ and Ra values. The effect of
the MOI on the overall gene expression of HSV-1 has
been investigated by Wagner and colleagues [50], who
found that, following the infection of cultured cells by
wild-type virus at MOIs ranging from 0.05 to 5 pfu/cell,
the temporal profiles of transcript abundance were
essentially the same. This is in sharp contrast with our
results. We explain the differences by the low resolution
of the microarray technique that Wagner et al. used for
their analysis. An analysis of the global transcription of
Rhesus monkey rhadinovirus, a g-herpesvirus, has
revealed differential gene expression at different MOIs
[48], but these data cannot be compared because they
related to later time points (12, 24, 48 72 and 96 h)
than in our analysis.
Conclusion
Our analysis has revealed that almost all of the exam-
ined PRV genes exhibited different expression dynamics
under the two experimental conditions. Most PRV
genes were expressed at a lower level in the low-MOI
than in the high-MOI experiment in the early stages of
infection; however, the reverse was true when the tran-
script levels were normalized to the genome copy num-
bers. In the low-MOI infection, slightly more than half
of the PRV transcripts outran the high-MOI values by 6
hp i .T h el o w e rie180 transcript per genome in the
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Page 8 of 11high-titre infection experiment might account for the
lower level of global PRV gene expression per genome
in the high-MOI infection. However, the expression of
viral genes per DNA did not uniformly decrease; some
genes even became more active in the high-MOI infec-
tion, which indicates the selective effect of the reduced
availability of the IE180 protein. The most dramatic dif-
ference between the two MOI infections was observed
in AST, which was expressed at a more than two log
higher level in an infected cell in the low-MOI infection,
which is a 3 log higher activity of a single DNA region
encoding the ASP. The ratio of LAT/EP0 was also sig-
nificantly lower in the high-than in the low-MOI infec-
tion. The reasons for and the mechanisms of these
phenomena remain to be clarified. Furthermore, genes
localized in adjacent regions on the viral genome exhib-
ited similar expression properties, indicating the exis-
tence of synchronizing mechanisms of gene expression.
Methods
Virus, cells and infection
Strain Kaplan (Ka) of pseudorabies virus (PRV) was used
in our analyses. Immortalized porcine kidney (PK)-15
epithelial cells were applied for propagation of the virus.
PK-15 cells were cultivated in Dulbecco’s modified Eagle
medium supplemented with 5% foetal bovine serum
(Gibco Invitrogen) and 80 μg gentamycin per ml at
3 7 ° Ci nt h ep r e s e n c eo fC O 2. The virus stock used
for the experiments was prepared as follows. Rapidly-
growing semi-confluent PK-15 epithelial cells were
infected at an MOI of 0.1 pfu/cell and were incubated
until a complete cytopathic effect was observed. The cell
debris was removed by low-speed centrifugation (10,000
g for 20 min). The supernatant was concentrated and
further purified by ultracentrifugation through a 30%
sugar cushion at 24,000 rpm for 1 h, using a Sorvall
AH-628 rotor. The number of cells in a culture flask
(Corning, 150 cm
2)w a s5×1 0
6. In high-MOI and in
low-MOI experiments, 5 × 10
7 and 5 × 10
5 pfu viral
particles, respectively, were applied for the infections.
Thus, in the high-MOI experiment, practically all the
cells were infected, while in the low-MOI experiment,
approximately 5 × 10
5 cells (10% of the cells in a culture
flask) were infected by the virus. We used the same data
for the low-MOI experiment as in a previous publica-
tion [1]. The two experiments were run simultaneously.
We ran four independent sets of measurements for each
time point in both low and high-MOI studies, but occa-
sionally we had to remove data because of low amplifi-
cation efficiencies or the amplification of non-specific
products in the reaction.” Thus, in some genes, instead
of four, we only used three independent data. Infected
cells were incubated for 1 h, followed by removal of the
virus suspension and washing with phosphate-buffered
saline. After the addition of new medium to the cells,
they were incubated for 0, 1, 2, 4 or 6 h. In this study,
mock-infected cells were used as controls, which were
otherwise treated in the same way as the infected cells.
Isolation of RNAs
RNA was extracted by using the NucleoSpin RNA II Kit
(Macherey-Nagel GmbH and Co. KG), as described pre-
viously [1]. Briefly, after the cells had been collected by
centrifugation and lysed by buffer containing chaotropic
ions, the nucleic acids were docked to a silica column.
The DNA was removed with RNase-free DNase solution
(supplied with the NucleoSpin RNA II Kit). Finally, the
RNAs were eluted from the column in RNase-free water
(supplied with the kit). To eliminate the residual DNA
contamination, all RNA samples were treated by an
additional digestion with Turbo DNase (Ambion Inc.).
The concentrations of the RNA samples were measured
by spectrophotometric analysis with a BioPhotometer
Plus instrument (Eppendorf). RNA samples were stored
at -80°C until further use.
Reverse transcription
0.07 μg of total RNA was reverse transcribed in a 5 μl
reaction volume, using SuperScript III Reverse Tran-
scriptase (Invitrogen), a gene-specific primer (1 μl),
dNTP mix (0.25 μl; 10 μM final concentration), and 5×
First-Strand Buffer (1 μl). The reaction mix was incu-
bated at 55°C for 60 min and incubation was stopped by
holding at 70°C for 15 min. A no-RT control reaction
was run to ensure that the RNA samples were free of
DNA contamination. For the quantitative RT-PCR reac-
tions, only DNA-free RNA samples were used. First-
strand cDNAs were diluted 10-fold with Nuclease-Free
Water (Promega Corp.) and stored at -80°C until use.
The same primers were used for the RT reaction as in
our previous publication [1].
Real-time PCR
A Rotor-Gene 6000 cycler (Corbett Life Science) was
used for the real-time quantitative PCR analysis. Each
reaction (20 μl final volume) contained the following
components: 7 μlo fc D N A s ,1 0μlo fA b s o l u t eQ P C R
SYBR Green Mix (Thermo Fisher Scientific), 1.5 μlo f
forward and reverse primer (10 μM each; we used the
same primer pairs as described earlier [1]). The PCR
cycling parameters were as follows: 95°C for 15 min
(pre-incubation), and then 30 cycles of 94°C for 25 sec
(denaturation), 60°C for 25 sec (annealing), and 72°C for
6 sec (extension). The specific amplification products
(with a single peak at the predicted temperature) were
identified by melting-point curve analysis. An additional
detection step was included in the cycle program to
avoid primer dimer detection for those primer pairs that
Tóth et al. BMC Microbiology 2010, 10:311
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Page 9 of 11produce primer dimers. The reliability of the primers
was verified in our earlier publication [1]. Porcine 28 S
rRNA was used as a loading control throughout the
experiment. H2O was included as a no-template control,
and cDNA derived from the reverse-transcribed RNAs
of non-infected cells was used as a negative mock-
infected control. SYBR Green-based real-time PCR was
applied in this study because of the low costs and simple
protocol [51].
Data analysis
The following formula was used for calculation of the
relative expression ratio (R):
R =
()
()
:
()
(
E
E
E
E
sample h
Ct
sample
Ct
ref h
Ct sample h
sample
ref h
6 6
6 6
r ref
Ctref )
where E is the efficiency of amplification, Ct is the cycle
threshold value, ‘sample’ is the examined PRV gene, and
‘ref’ is the 28 S rRNA. The Comparative Quantitation
module of the Rotor-Gene 6000 Software (Version
1.7.87., Corbett Research) was used to calculate the real-
time PCR efficiency for each sample. Thresholds were set
by the software. The R values of both low and high-titre
infections were maximized to the 6 h E
Ct values of the
high-MOI experiment. To measure the net change in R
between two consecutive time points, RΔ was calculated
via the following formula: RΔ =R (t+1)-Rt.T h er a t eo f
change was calculated as follows: Ra =R (t+1)/Rt. Pearson’s
correlation was used for the analysis of the relationship
between low- and high-titre infections using the follow-
ing formula [52]:
r =
−−
−
= ∑() ( )
()
XX YY
nS S
ii
i
n
xy
1
1
The correlation measures the linear relationship
between two variables, X and Y. Pearson’s coefficient (r)
is a number ranging from -1 to +1 that measures the
degree of association between X and Y. If X and Y are
independent, Pearson’s correlation coefficient is 0. A
positive r value for the correlation implies a positive
association (large values of X tend to be associated with
large values of Y, and small values of X tend to be asso-
ciated with small values of Y). A negative value for the
correlation means an inverse association (large values of
X tend to be associated with small values of Y, and vice
versa). In the analysis of the relationship between the
low and high-titre infections, X is the average R value
of the low-titre infection at a given time point, and Y is
t h ea v e r a g eRv a l u ea tt h es a m et i m ep o i n ti nt h eh i g h -
titre infection. SX and SY are the SEM (standard error of
the mean) values and n is the sample number.
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